UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

AENZA S.A.A.

(Formerly Graña y Montero S.A.A.)

(Name of Issuer)

Common Shares, par value S/ 1.00 per share

(Title of Class of Securities)

00776D 103**

(CUSIP Number)

**CUSIP number of the American Depositary Shares (“ADSs”) listed on the New York Stock Exchange. Each ADS represents five common shares. The common shares are listed on the Lima Stock Exchange and the CINS Identifier is PEP736581005.

Andrew Cunningham
Director

IG4 Capital Infrastructure GP Limited
50 La Colomberie, St. Helier, Jersey, JE2 4QB

+44.1534.844234

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

August 6, 2021

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g) check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

This Amendment No. 1 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Persons on July 12, 2021 (the “Initial Schedule 13D” and together with the Amendment, the “Schedule 13D”) with respect to the Company. Capitalized terms used in this Amendment and not otherwise defined have the same meanings ascribed to them in the Initial Schedule 13D. Unless specifically amended hereby, the disclosure set forth in the Initial Schedule 13D remains unchanged.

The information contained in Item 3 of the Initial Schedule 13D is hereby amended and supplemented to include the following information:

As described in more detail in Items 4 and 5 below, as of August 6, 2021 the Reporting Persons may be deemed to beneficially own: (i) 107,198,601 Common Shares, representing approximately 12.29% of the then outstanding Common Shares, as a result of the consummation of the Offers (the “Accepted Shares”) and (ii) 111,945,909 Common Shares, representing approximately 12.8% of the then outstanding Common Shares, as a result of the arrangements made pursuant to the Amended GH Syndication Agreement, the Amended HG Syndication Agreement and the MA Syndication Agreement and the Trust Agreement, as disclosed in the Initial Schedule 13D.

On August 10, 2021, the settlement date of the Offers, Purchaser will pay the aggregate purchase price of S/ 201,533,370 for the Accepted Shares. Based on the average Peruvian Sol/U.S. dollar interbank exchange rate (tipo de cambio interbancario promedio) reported by the Central Reserve Bank of Peru at 2:00 p.m., Lima time, on August 6, 2021, the last full trading day prior to the publication of this Amendment, the aggregate purchase price payable by Purchaser upon the consummation of the Offers would be approximately U.S. $49,240,952.40. The funds to be used to purchase the Accepted Shares were provided to Purchaser by IG4. The Offers are being financed with funds from IG4 Capital Private Equity Fund II, additional capital from co-investors and existing liquidity.

The information contained in Item 4 of the Initial Schedule 13D is hereby amended and supplemented to include the following information:

The information set forth in Items 3 and 5 of this Amendment is hereby incorporated by reference in this Item 4.

The Offers expired on August 5, 2021.

On August 6, Purchaser filed a Schedule TO-T/A announcing the final results of the Offers, including the results of the application of proration.

On August 6, 2021, Purchaser accepted for payment the Accepted Shares at S/ 1.88 per Common Share.

The information contained in Item 5 of the Initial Schedule 13D is hereby amended and supplemented to include the following information:

The information set forth in Item 4 of this Amendment and the responses of the Reporting Persons to Rows (11) through (13) of the cover pages of this Amendment are incorporated herein by reference.

(a) – (b)

The calculation of this percentage is based on an aggregate 871,917,855 Common Shares outstanding as of June 30, 2021, as set forth in the Form 6-K filed by the Company with the SEC on July 26, 2021.

Each Reporting Person may be deemed to share the power to (i) vote or to direct the vote of 219,144,510 Common Shares in the aggregate, representing approximately 25.13% of the outstanding Common Shares as a result of the consummation of the Offers and the arrangements made pursuant to the Amended GH Syndication Agreement, the Amended HG Syndication Agreement and the MA Syndication Agreement and the Trust Agreement (as disclosed in the Initial Schedule 13D) and (ii) dispose or direct the disposition of 107,198,601 Common Shares in the aggregate, representing approximately 12.29% of the outstanding Common Shares.

Except as disclosed in the Schedule 13D, none of the Reporting Persons nor, to the best of their knowledge, any of the other persons identified in Item 2, has the power to vote or to direct the vote or to dispose or direct the disposition of any of the Common Shares which it may be deemed to beneficially own.

(c)       

As described in more detail in Item 4 above, on August 6, 2021, Purchaser accepted for payment the Accepted Shares. The information set forth in Item 4 is hereby incorporated by reference.

Except for the foregoing, no other transactions in the Common Shares were effected by the Reporting Persons, nor, to the best of their knowledge, any of the other persons identified in Item 2, during the sixty (60) days prior to the date of this Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: August 9, 2021

[Signature page to Schedule 13D/A]

Aenza SAA (NYSE:AENZ)
Historical Stock Chart
Von Jun 2022 bis Jul 2022

Aenza SAA (NYSE:AENZ)
Historical Stock Chart
Von Jul 2021 bis Jul 2022